First International Conference of Liver Pathobiology: From Bench to Bedside


Important: The program online is copyrighted to each author and should not be copied and pasted!
Systems Pathophysiological Modeling of Metabolic Reprograming in Alcoholic Hepatitis
Alexandra Manchel1, Radhakrishnan Mahadevan2, Ramon Bataller3, Jan Hoek1, and Rajanikanth Vadigepalli1
Outcome of Targeting ATR in High Replication Stress Murine HCC
FANG Jing1, HE Qiyuan1, PAN Long3, DONNE Romain 2, ARAUJO Joana 1, POPHILLAT Céline 1, KABORE Christelle 1, COUTY Jean-Pierre 1, ZUCMAN-ROSSI Jessica 3, LUJAMBIO Amaya 2, MORIZUR Séverine 1, and DESDOUETS Chantal 1
Exploring Aspirin's Role in Mitigating Liver Cancer Development: Insights from a NASH Mouse Model
Nur Dianah Abu Bakar
Zhen Sun
Altered profiles of circulating cytokines in chronic liver diseases (NAFLD/HCC): impact of the PNPLA3-I148M risk allele
Mélanie Kirchmeyer1, Anthoula Gaigneaux1, Florence Servais1, Anita Arslanow2,3, Markus Casper3, Marcin Krawczyk3, Frank Lammert3,4, and Iris Behrmann1
Development of a precision bio-printed liver tumour patient-derived organoid platform
Gayatri Shirolkar1,6, Sara Pasic1,6, Jonathan Tibballs2,6, Shirley Go2,6, Rachel Way4,6, Michael Wallace2,5,6, Louise Winteringham3,6, Peter Leedman3,6, Janina Tirnitz-Parker1,3,6, and Benjamin Dwyer1,6
Transcriptional Master Regulators as Therapeutic Targets in Hepatocellular Carcinoma
Yoshinobu Saito1, Ajay Nair1, Qiuyan Sun1, Marcella Steffani1, Kirk Wangensteen2, Andrea Califano1, and Robert Schwabe1
Beneficial effects of hepatic cyclooxygenase-2 expression against NAFLD/NASH: a potential therapeutic target
María Luque-Tévar1,2, Carme Cucarella1,2, Marina Fuertes-Agudo1,2, Paloma Martín-Sanz2,3, and Marta Casado1,2
Identifying drivers of liver cancer using CRISPR activation screening in vivo
Alexandra Vázquez Salgado1, Markcus Lee1, Shirui He2, and Kirk Wangensteen1
Extracellular Matrix Protein 1 and the short Peptide KTFR prevent protease-mediated Latent Transforming Growth Factor-β1 Activation, subsequent Hepatic Stellate Cell Activation and revert Liver Injury and Fibrosis following Extracellular Matrix Protein 1 Knockout
Frederik Link1, Yujia Li1, Stefan Munker2,3, Zeribe Nwosu4, Weiguo Fan5, Honglei Weng1, Matthias Ebert1,6, Steven Dooley1, and Sai Wang1
Epigenetic regulation by UHRF1 in the aging liver
Yousra Ajouaou, Filippo Macchi, Shuang Wang, and Kirsten Sadler Edepli
Combined high-resolution digital histomorphometry and second harmonic generation-based collagen characterization reveals spatial context in liver fibrosis and cancer
Thomas Sorz1,2,3, Oleksandr Petrenko1,2,3, Benedikt Simbrunner1,2,3,4, Kerstin Zinober1,3,4, Georg Semmler1,4, Philipp Königshofer1,3,4, Christopher Kaltenecker5, Frank Assen6, Benedikt Hofer1,2,3,4, Behrang Mozayani5, Renate Kain5, Wolfgang Weninger6, Michael Trauner1, Philipp Schwabl1,2,3,4, and Thomas Reiberger1,2,3,4
Dysregulated sphingolipid metabolism in MASH-HCC
Huiping Zhou, Jing Zeng, Derrick Zhao, Xuan Wang, and Phillip Hylemon
Macrophage mediated senescent cell elimination in a liver cancer model in zebrafish
Elena Magnani, Charlene Chen, Filippo Macchi, Ian McBain, and Kirsten Sadler
Alpha-smooth-muscle actin represents a histologic surrogate of regressive vs. progressive cirrhosis
Thomas Sorz1,2,3, Benedikt Simbrunner1,2,3,4, Kerstin Zinober1,3,4, Georg Semmler1,4, Philipp Königshofer1,3,4, Christopher Kaltenecker5, Oleksandr Petrenko1,2,3, Benedikt Hofer1,2,3,4, Behrang Mozayani5, Vlad Taru1,3, Renate Kain5, Michael Trauner1, Matthias Mandorfer1,4, Philipp Schwabl1,2,3,4, and Thomas Reiberger1,2,3,4
Carrot Edible Exosomes Potentiates a Therapy for Hepatic Encephalopathy by Modulating Gut Microbiota and Reducing Ammonia levels
Sukriti Baweja, P Debishree Subudhi, Chhagan Bihari, and Shiv Sarin
In Vivo Tracking and 3D Mapping of Cell Death during Liver Regeneration and Cancer
Ivan Moya1,2 and Georg Halder2
Disease-specific human ECM composition and bioactivity in NASH liver fibrosis
Lisa Longato
Gut and Circulating Bacterial Vesicles and their Virulence Factors Increase with Severity of Autoimmune Hepatitis
Sukriti Baweja, Swati Thangariyal, Chhagan Bihari, and Shiv Sarin
Pathway analysis including miRNA function.
Artemis Hatzigeogriou, Spyros Tastsoglou, Giorgos Skoufos, Marios Miliotis, and Filippos Kardaras